• 제목/요약/키워드: Maximum Dose

검색결과 1,212건 처리시간 0.027초

고에너지 전자선의 방사선 치료 기술 (Radiotherapy Technique of High Energy Electron)

  • 서명원;박재일;최홍식;김우열
    • 대한방사선치료학회지
    • /
    • 제1권1호
    • /
    • pp.63-69
    • /
    • 1985
  • High energy electron beams took effect for tumor radio-therapy, however, had a lot of problems in clinical application because of various conversion factors and complication of physical reactions. Therefore, we had experimentally studied the important properties of high energy electron beams from the linear accelerator, LMR-13, installed in Yonsei Cancer Center. The results of experimental studies on the problems in the 8, 10, 12 Mev electron beam therapy were reported as following. 1. On the measurements of the outputs and absorbed does, the ionization type dosimeters that had calibrated by $^{90}Sr$ standard source were suitable as under $3\%$ errors for high energy electrons to measure, but measuring doses in small field sizes and the regions of rapid fall off dose with ionization chambers were difficult. 2. The electron energy were measured precisely with energy spectrometer consisted of magnet analyzer and tele-control detector and the practical electron energy was calculated under $5\%$ errors by maximum range of high energy electron beam in the water. 3. The correcting factors of perturbated dose distributions owing to radiation field, energy and material of the treatment cone were checked and described systematically and variation of dose distributions due to inhomogeneous tissues and sloping skin surfaces were completely compensated. 4. The electron beams, using the scatters; i.e., gold, tin, copper, lead, aluminium foils, were adequately diffused and minimizing the bremsstrahlung X-ray induced by the electron energy, irradiation field size and material of scatterers, respectively. 5. Inproving of the dose distribution from the methods of pendulum, slit, grid and focusing irradiations, the therapeutic capacity with limited electron energy could be extended.

  • PDF

필름 및 tissue equivalent 팬톰을 이용한 NEC LINAC 6 MVX 소조사면에 대한 선량분포 측정 (Measurement of Dose Distribution in Small Fields of NEC LINAC 6 MVX Using Films and Tissue Equivalent Phantoms)

  • Suh, Tae-Suk;Park, Dong-Rak;Choe, Bo-Young;Yoon, Sei-Chul;Jang, Hong-Seok;Park, Il-Bong;Kim, Moon-Chan;Bahk, Yong-Whee;Shin, Kyung-Sub
    • 한국의학물리학회지:의학물리
    • /
    • 제4권2호
    • /
    • pp.9-17
    • /
    • 1993
  • 본 논문의 목적의 NEC LINAC 6 MVX 선의 소조사면에 대한 선량분포를 복잡한 물팬톰 및 ion chamber대신 film 및 고체 물팬톰을 이용하여 간단히 측정하고 분석하는 시스템을 개발하는 데 있다. 단일 선속측정을 위하여 필름과 고체 물팬톰이 이용되었으며, 측정된 데이타는 percent depth dose (PDD), off-axis ratio (OAR) 등을 포함하며, 한변이 1, 2, 3cm의 정사각형 소조사면에 대하여 측정이 이루어 졌다. 또한 Output factor측정은 ion chamber로 측정되었으며, 필름에 의하여 측정된 PDD, OAR 등은 ion chamber측정기로 측정된 값과 비교 검토되었다. 필름으로 부터 측정된 PDD값으로 부터 환산식을 이용하여 tissue maximum ratio (TMR) 값을 얻었으며, 본 실험에서 얻어진 TMR, OAR 값들은 같은 에너지를 나타내는 Philips LINAC의 선량 데이타와 유사한 결과를 보여주었다. 고체 물팬톰 및 필름을 이용한 소조사면 측정은 간편하고도 유용한 방법이었으며, 특히, 자체 개발된 필름팬톰은 뇌정위적 방사선 수술을 위한 OAR 선량을 측정하는 데 유용하였다.

  • PDF

한약의 안전성 등급화를 통한 근거중심실용의학적 연구(1) - Aristolochic acid 함유 한약재를 중심으로 - (Introduction of evidence-based practical medicine through safety classification for herbal medicine(1))

  • 박영철;이선동
    • 대한한의학회지
    • /
    • 제35권1호
    • /
    • pp.114-123
    • /
    • 2014
  • Objectives: Evidence-based medicine(EBM) advocates the use of up-to-date "best" scientific evidence from health care research as the basis for making medical decisions. EBM also has been applied to traditional Korean medicine(TKM), especially in the field of safety. Recently, the standard prescription for TKM by Korea Institute of Oriental Medicine was published based on toxic index from various toxicity tests. However, there are some limitations when the results from the study based on EBM are applied in clinics. To overcome these imitations, the term "evidence-based practical medicine" was developed and defined as clinically applicable results from the study based on EBM. And safety classification for TKM was suggested as an example of evidence-based practical medicine. Methods: For safety classification for TKM, the data for $LD_{50}$(50% lethal dose), which was transformed to theoretical $LD_1$(1% lethal dose), was analyzed as one of tools for EMB study and divided by maximum dose used in clinics. Results and Conclusions: As a result, human equivalent dose(HED)-based MOS(margin of safety) for korean traditional medicine was calculated and used for safety classification with 5 categories. These categories would be helpful for oriental medicine clinicians to decide the increase and decrease of dosage according to various factors such as patient's sensitivity, potential toxicity of herbal medicines, clinician's experience for better cure. Thus, this safety classification provides some evidences enough that evidence-based practical medicine should be not the same with EBM and defined differently from EBM.

비글견을 이용한 GST 추출물의 단회 경구투여 용량증가 독성시험 (A Single Oral Dose Toxicity Test of GST in Beagle Dogs)

  • 이철화;양원경;정인철;진미림;김승형;박양춘
    • 대한한방내과학회지
    • /
    • 제37권1호
    • /
    • pp.8-15
    • /
    • 2016
  • Objectives: To provide information on the safety of GST (Gami-Sasangja-tang), we carried out a single oral dose-increasing toxicity test of GST in beagle dogs.Materials and Methods: Six beagle dogs (three males and three females) were randomly assigned to two groups (experimental group: n=4, control group: n=2). The experimental group (two males, two females) was given oral doses of GST in increasing order (1,250, 2,500, and 5,000 mg/kg) at three-day intervals. After administration, the participants’ mortality, clinical signs, and body weight changes were monitored for two weeks. After two weeks, all dogs were sacrificed for autopsy.Results: Temporary vomiting was observed according to increasing dosage (n=1, 250 mg/kg; n=4, 2,500 and 5,000 mg/kg). Transient diarrhea was observed on the second and third dosing day (n=1, 2,500 mg/kg; n=2, 5,000 mg/kg). Temporary salivation was noted on the third dosing day (n=3, 5,000 mg/kg). Compound-colored stool was observed in all dogs fed the GST on all dosing days and also on the following days. We found no mortality and no abnormalities in the clinical signs, body weight, and gross findings in any of the dogs tested.Conclusions: The maximum tolerated dose was over 5,000 mg/kg for both male and female dogs.

Image Guided Brachytherapy in Cervix Cancer

  • Park, Sung-Yong;Shin, Kyung-Hwan;Park, Dahl;Cho, Jung-Keun;Kim, Dae-Yong;Kim, Jong-Won;Cho, Kwan-Ho;Kim, Tae-Hyun;Chie, Eui-Kyu
    • 한국의학물리학회:학술대회논문집
    • /
    • 한국의학물리학회 2002년도 Proceedings
    • /
    • pp.154-156
    • /
    • 2002
  • Brachytherapy has a long history in the treatment of cancer. However, the treatment planning technique for brachytherapy has lagged somewhat behind the corresponding developments for external beam therapy as far as the imaging technique is concerned. Currently, the orthogonal-film-based treatment planning is performed at most institutions even though the CT-based planning is available. The aim of this study is to evaluate the CT-based vs. the orthogonal-film-based treatment planning in cervix cancer. The doses to point A, point B, rectum and bladder points according to ICRU 38 were calculated for the two methods above. In addition, the volumetric studies such as 3D dose computation and DVH were obtained for the CT-based planning. For the bulky tumor, the isodose lines of point A prescription were not fairly covered for the CTV. The CT -based dose planning can overestimate the maximum dose delivered to bladder and rectum by 30%. The CT-based planning has several advantages over the orthogonal-film-based such as 3D dose display, DVH, and more accurate target delineation. It is suggested that the prescription point in cervix cancer be revised especially for the bulky tumor.

  • PDF

166Ho-chitosan 복합체의 복강 내 투여를 위한 베타선 흡수선량 평가 (Beta Dosimetry in Intraperitoneal Administration of 166Ho-chitosan Complex)

  • 김은희;임상무;박경배
    • 대한핵의학회지
    • /
    • 제32권1호
    • /
    • pp.99-108
    • /
    • 1998
  • Intraperitoneal administration of radioisotopes is suggested to treat the metastatic ovarian cancer in the peritoneal cavity. Administering beta-emitting radioisotopes into the peritoneal cavity allows the maximum energy delivery to the cancerous cells of the peritoneal wall surface while sparing the normal cells located in deep site of the peritoneal wall. In this study, dose estimates of the peritoneal wall are provided to be used for prescribing the amount of $^{166}Ho$-chitosan complex administered. The $^{166}Ho$-chitosan complex diffused in the peritoneal fluid may attach to the peritoneal wall surface. The attachment fraction of $^{166}Ho$-chitosan complex to the peritoneal wall surface is obtained by simulating the ascites with Fischer rats. Both volume source in the peritoneal fluid and the surface source over the peritoneal wall surface are counted for the contribution to the peritoneal wall dose. The Monte Carlo code EGS4 is used to simulate the energy transfer of the beta particles emitted from $^{166}Ho$. A plane geometrical model of semi-infinite volume describes the peritoneal cavity and the peritoneal wall. A semi-infinite plane of $10{\mu}m$ in thickness at every 1 mm of depth in the peritoneal wall is taken as the target in dose estimation. Greater than 98 percents of attachment fraction has been observed from the experiments with Fischer rats. Given $1.3{\mu}Ci/cm^2$ and $2.4{\mu}Ci/ml$ of uniform activity density, absorbed dose is 123 Gy, 8.59 Gy, 3.00 Gy, 1.03 Gy, and .327 Gy at 0 mm, 1 mm, 2 mm, 3 mm, and 4 mm in depth to the peritoneal wall, respectively.

  • PDF

Synergistic Effect of Ethaselen and Selenite Treatment against A549 Human Non-small Cell Lung Cancer Cells

  • Xu, Wei;Ma, Wei-Wei;Zeng, Hui-Hui
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제15권17호
    • /
    • pp.7129-7135
    • /
    • 2014
  • Background: In this study, we aimed to evaluate the growth inhibitory effect of the combination of ethaselen (BBSKE) and low fixed dose of selenite against A549 human non-small cell lung cancer cells in vitro. Materials and Methods: Growth inhibitory effects against A549 cells were determined by SRB assay. Combination index (CI) values were calculated based on Chou-Talalay median-effect analyses. Dose reduction index (DRI) values were applied to calculate dose reduction of selenite. Contents of free thiols and GSH were determined by DTNB assay and intracellular ROS levels by DCFH-DA fluorescence labeling. Results: Compared with BBSKE or selenite single treatment, the combined application of ethaselen and a low fixed dose of selenite shortened the onset time of sodium selenite, reduced $IC_{50}$ values, and increased the maximum inhibition rates, suggesting a possible molecular mechanism of the synergism. Obvious synergistic effects were observed after different times of combination treatment, especially after 24 h. Compared with selenite single treatment, dosage of selenite could be remarkably reduced in combination therapy to gain the same inhibitory effect on cell proliferation. Compared with BBSKE single treatment, the content of free thiols and GSH were significantly reduced and ROS levels greatly elevated in the combination group. For the combination treatment, cell viability increased as greater concentrations of GSH were added. Conclusions: All these results indicate that the combination treatment of BBSKE and selenite showed synergism to inhibit A549 cell proliferation in vitro, and also reduced the selenite dosage to mitigate its toxicity which is very meaningful for combination chemotherapy of lung cancer. The synergism was probably caused by the accelerated exhaustion of intracellular reductive substances, such as free thiols and GSH, which ultimately leads to enhanced oxidative stress and apoptosis.

생약복합제 SKI306X의 랫드에 대한 4주 경구 반복투여 독성연구 (Subacute Toxicity of SKI306X, an Antiinflammatory Herbal Extracts, in Rats)

  • 김훈택;안재석;정인호;김택수;류근호;임광진;조용백;김대기;김환수
    • Biomolecules & Therapeutics
    • /
    • 제4권1호
    • /
    • pp.19-31
    • /
    • 1996
  • This study was performed to determine the subacute toxicities of SKI306X, an antiinflammatory herbal extract, in rats. SKI306X was administered orally to rats once a day for 4 weeks at doses of 0.3, 1.0, and 3.0 g/kg/ day. Each group consisted of 20 male and 20 female rats, including 5 male and 5 female rats per group for an interim study at the end of 2-week administration and for a 2-week recovery study, respectively. Throughout the study, all rats survived and no adverse clinical signs were observed. Although male rats treated with high dose (3.0 g/kg/day) of SKI306X showed slight loss of body weight (approximately 5%) in comparison with control animals during the administration period, their body weight loss was normally restored during the recovery period. No significant change was found in all hematological parameters of SKI306X-treated groups except for the decreased number of red blood cells in all female groups at the interim study. Statistically significant changes were observed in several blood enzyme levels of SKI306X-treated groups; however, most of these significant changes were within normal range and statistically significant values did not show dose-related responses. In SKI306X-treated groups, the absolute and relative weights of liver, heart, and stomach were statistically different from those of control group, but these differences disappeared at the end of recovery period and also drug-related gross and histopathological findings in these organs were not found. No other drug-related gross and histopathological findings were observed. It is concluded from the results of this study that non-toxic dose of SKI306X was estimated to be between 0.3 and 1.0 g/kg/day and the maximum tolerated dose of SKI306X was assumed to be higher than 3.0 g/kg/day.

  • PDF

Dosimetric Comparison of 6 MV Flattening Filter Free and 6 MV Stereotactic Radiosurgery Beam Using 4 mm Conical Collimator for Trigeminal Neuralgia Radiosurgery

  • Mhatre, Vaibhav R;Chadha, Pranav;Kumar, Abhaya P;Talapatra, Kaustav
    • Journal of Radiation Protection and Research
    • /
    • 제43권3호
    • /
    • pp.107-113
    • /
    • 2018
  • Background: The purpose of our study was to compare the dosimetric advantages of Flattening filter free (FFF) beams for trigeminal neuralgia patients using 4 mm conical collimators over previously treated patients with 6 MV SRS beam. Materials and Methods: A retrospective study was conducted for 5 TN patients who had been previously treated at our institution using frame-based, LINAC-based stereotactic radiosurgery (SRS) on Novalis Tx using 6 MV SRS beam were replanned on 6X FFF beams on Edge Linear accelerator with same beam angles and dose constraints using 4 mm conical collimator. The total number of monitor units along with the beam on time was compared for both Edge and Novalis Tx by redelivering the plans in QA mode of LINAC to compare the delivery efficiency. Plan quality was evaluated by homogeneity index (HI) and Paddick gradient index (GI) for each plan. We also analyzed the doses to brainstem and organ at risks (OARs). Results and Discussion: A 28% beam-on time reduction was achieved using 6X FFF when compared with 6X SRS beam of Novalis Tx. A sharp dose fall off with gradient index value of $3.4{\pm}0.27$ for 4 mm Varian conical collimator while $4.17{\pm}0.20$ with BrainLab cone. Among the 5 patients treated with a 4 mm cone, average maximum brainstem dose was 10.24 Gy for Edge using 6X FFF and 14.28 Gy for Novalis Tx using 6X SRS beam. Conclusion: The use of FFF beams improves delivery efficiency and conical collimator reduces dose to OAR's for TN radiosurgery. Further investigation is warranted with larger sample patient data.

$CaSO_4$:Tm-PTFE TLD를 이용한 고에너지 전자선의 흡수선량 측정 (Measurement of Absorbed Dose for High Energy Electron using $CaSO_4$:Tm-PTFE TLD)

  • 박명환;김도성;도시홍;김완;강희동
    • 센서학회지
    • /
    • 제10권5호
    • /
    • pp.314-319
    • /
    • 2001
  • $CaSO_4$:Tm 열형광체 분말 20wt%를 PTFE와 혼합하여 직경 8.5mm, 두께 $90mg/cm^2$로 압축 성형한 후 중합하여 디스크 형태의 $CaSO_4$:Tm-PTFE TLD소자를 제작하였다. $^{60}Co$ 원격조사장치를 이용하여 0.5Gy의 $\gamma$-선을 조사한 TLD 소자의 균일성은 3.1%로 우수하였다. 이 중에서, 선별한 TLD를 이용하여 고에너지 전자선에 대한 polystyrene 팬톰에서의 흡수선량 분포를 측정하여 최대선량깊이, 50%선량깊이 및 실용비정의 값을 구할 수 있었으며, 조사야 내의 beam 평탄도는 4.5%로 나타났다. 이들 값은 dosimetry system으로 측정한 결과와 비교하여 다소 증가하는 경향을 나타내었다.

  • PDF